补肾祛瘀活血汤治疗慢性肾小球肾炎患者的效果分析

doi:10.3760/cma.j.issn.1007-1245.2022.16.027

摘要/Abstract

摘要： 目的　探讨补肾祛瘀活血汤对慢性肾小球肾炎患者肾功能及血脂的影响。方法　本研究为前瞻性研究。选取2019年7月至2021年7月临清市人民医院收治的96例慢性肾小球肾炎患者，按随机数字表法将其分为对照组和试验组，每组48例。对照组男25例，女23例，年龄（49.67±8.52）岁；试验组男26例，女22例，年龄（49.53±8.67）岁。两组均予以常规治疗，同时对照组给予氯沙坦治疗，试验组在对照组的基础上给予补肾祛瘀活血汤治疗，两组均连续治疗6个月。比较两组治疗后临床疗效，治疗前后肾功能、血脂指标水平，治疗期间不良反应情况。统计学方法采用独立样本t检验、配对t检验、χ²检验。结果　治疗后试验组临床总有效率与对照组相比升高［93.75%（45/48）比79.17%（38/48）］，两组比较差异有统计学意义（χ²=4.360，P=0.037）；治疗后试验组的血清肌酐（Scr）、尿素氮（BUN）、24 h尿蛋白定量（24 h UP）、三酰甘油（TG）、总胆固醇（TC）、低密度脂蛋白胆固醇（LDL-C）水平均低于对照组［（89.46±10.34）μmol/L比（125.35±14.18）μmol/L、（3.27±0.52）mmol/L比（6.58±0.75）mmol/L、（0.76±0.12）g/24 h比（1.45±0.27）g/24 h、（1.51±0.35）mmol/L比（2.13±0.37）mmol/L、（4.83±0.57）mmol/L比（6.76±0.75）mmol/L、（1.72±0.24）mmol/L比（3.15±0.45）mmol/L］，差异均有统计学意义（均P<0.001）；与治疗前比较，治疗后两组患者的肾小球滤过率（GFR）、血清高密度脂蛋白胆固醇（HDL-C）水平均升高，且试验组的GFR、HDL-C水平均高于对照组［（91.18±6.16）ml/（min·1.73 m²）比（75.35±9.74）ml/（min·1.73 m²）、（1.48±0.25）mmol/L比（1.16±0.23）mmol/L］，差异均有统计学意义（均P<0.001）。两组治疗期间均无严重不良反应出现。结论　补肾祛瘀活血汤治疗慢性肾小球肾炎，可有效缓解患者的临床症状，改善肾功能，调节血脂水平，且疗效显著。

关键词: 慢性肾小球肾炎, 补肾祛瘀活血汤, 肾功能, 血脂

Abstract: Objective　To investigate the effects of Bushen Quyu Huoxue decoction on the renal function and blood lipid in patients with chronic glomerulonephritis. Methods　It was a prospective study. A total of 96 cases of chronic glomerulonephritis were selected from The People's Hospital of Linqing from July 2019 to July 2021, and they were divided into a control group (48 cases) and an experimental group (48 cases) with the random number table method. There were 25 males and 23 females in the control group, aged (49.67±8.52) years; there were 26 males and 22 females in the experimental group, aged (49.53±8.67) years. Both groups were given routine treatment, the control group was given losartan treatment, and the experimental group was given Bushen Quyu Huoxue decoction on the basis of the control group. The two groups received continuous treatment for 6 months. The clinical effect, renal function, blood lipid level, and adverse reactions during the treatment were compared between the two groups. Independent sample t test was used for inter-group comparison of the measurement data, paired t test was used for intra-group comparison of the measurement data, and χ² test was used for the count data. Results　After treatment, the total clinical effective rate of the experimental group was higher than that of the control group [93.75% (45/48) vs. 79.17% (38/48)], with a statistically significant difference (χ²=4.360, P=0.037). After treatment, the levels of serum creatinine (Scr), urea nitrogen (BUN), 24 h urine protein quantification (24 h UP), triglyceride (TG), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C) in the experimental group were lower than those in the control group [(89.46±10.34) μmol/L vs. (125.35±14.18) μmol/L, (3.27±0.52) mmol/L vs. (6.58±0.75) mmol/L, (0.76±0.12) g/24 h vs. (1.45±0.27) g/24 h, (1.51±0.35) mmol/L vs. (2.13±0.37) mmol/L, (4.83±0.57) mmol/L vs. (6.76±0.75) mmol/L, (1.72±0.24) mmol/L vs. (3.15±0.45) mmol/L], with statistically significant differences (all P<0.001). After treatment, the glomerular filtration rates (GFR) and serum high density lipoprotein cholesterol (HDL-C) levels in the two groups were increased compared with those before treatment, and the GFR and HDL-C in the experimental group were higher than those in the control group [(91.18±6.16) ml/(min•1.73 m²) vs. (75.35±9.74) ml/(min•1.73 m²), (1.48±0.25) mmol/L vs. (1.16±0.23) mmol/L], with statistically significant differences (all P<0.001). No serious adverse reactions were observed in the two groups during the treatment. Conclusion　Bushen Quyu Huoxue decoction can effectively relieve the clinical symptoms in patients with chronic glomerulonephritis, improve their renal function, and regulate the blood lipid level, with a significant effect.

Key words: Chronic glomerulonephritis, Bushen Quyu Huoxue decoction, Renal function, Blood lipid

徐立娜　王文颖 . 补肾祛瘀活血汤治疗慢性肾小球肾炎患者的效果分析[J]. 国际医药卫生导报, 2022, 28(16): 2335-2338.

Xu Lina, Wang Wenyin. Effect analysis of Bushen Quyu Huoxue decoction in the treatment of patients with chronic glomerulonephritis[J]. International Medicine and Health Guidance News, 2022, 28(16): 2335-2338.

参考文献

[1] botareva NV, Berns AS, Lebedeva M , et al. Clinical impact of plasma haemostasis disorders and their correction in chronic glomerulonephritis with nephrotic syndrome[J]. GematologiiaiTransfuziologiia, 2020, 65(4):473-482. DOI:10.35754/0234-5730-2020-65-4-473-482.
[2] 黄添翼,李晨嫣,刘大军. ZO-1和occludin表达水平与慢性肾小球肾炎患者肾功能的关系[J]. 热带医学杂志,2022,22(2):165-169,封2. DOI:10.3969/j.issn.1672-3619.2022. 02.005.
[3] 赵大鹏,张媛媛,王茹,等. 李延教授治疗慢性肾小球肾炎经验浅析[J]. 天津中医药大学学报,2020,39(4):385-388. DOI:10.11656/j.issn.1673-9043.2020.04.05.
[4] 巩昭勇,黄芳,薛丕良,等. 活血益肾汤联合氯沙坦钾治疗慢性肾小球肾炎疗效及对血脂和炎症反应的影响[J]. 现代中西医结合杂志,2019,28(23):2587-2589. DOI:10.3969/j.issn.1008-8849.2019.23.021.
[5] 杨敬,郑劲,钟锦,等. 补肾清利活血汤对慢性肾小球肾炎患者肾功能及炎症状态的影响[J]. 中国中西医结合肾病杂志,2020,21(2):153-155,190. DOI:10.3969/j.issn.1009- 587X.2020.02.020.
[6] 梅长林, 余学清. 内科学(肾脏内科分册)[M]. 北京: 人民卫生出版社, 2015: 45-46.
[7] 国家中医药管理局. 中医病证诊断疗效标准[M]. 南京: 南京大学出版社, 1994: 56-57.
[8] 郑剑,孙妲男,李勇,等. 温阳补肾汤对慢性肾小球肾炎脾肾阳虚证患者尿液Cys C、α1-MG表达及T淋巴细胞亚群的影响[J]. 湖南中医药大学学报,2021,41(7):1115-1119. DOI:10.3969/j.issn.1674-070X.2021.07.025.
[9] 周威,胡斌,贡方红,等. 小柴胡汤联合小剂量苯磺酸左旋氨氯地平治疗慢性肾小球肾炎临床研究[J]. 新中医,2020,52(20):39-41. DOI:10.13457/j.cnki.jncm.2020.20.011.
[10] 钟瑜,朱芸芸,徐再春. 益肾清利活血法治疗慢性肾小球肾炎的临床研究[J]. 中华中医药学刊,2017,35(6):1567- 1569. DOI:10.13193/j.issn.1673-7717.2017.06.058.
[11] 裴国超,马金荣,赵丽,等. 益肾清利活血方治疗肾虚湿瘀型慢性肾小球肾炎疗效及对患者尿常规、肾功能的影响[J]. 陕西中医,2022,43(4):483-486. DOI:10.3969/j.issn.1000- 7369.2022.04.018.
[12] 党同光,满中萍,景舒梦. 阿托伐他汀联合缬沙坦治疗慢性肾炎患者的临床有效率分析[J]. 国际医药卫生导报,2019,25(9):1454-1456. DOI:10.3760/cma.j.issn.1007-1245. 2019.09.029.
[13] 张城浩,潘秋霞,王杰鹏,等. 中医外治法治疗慢性肾炎的研究进展[J]. 现代中西医结合杂志,2016,25(19):2161-2163. DOI:10.3969/j.issn.1008-8849.2016.19.039.
[14] 钱祎玲,周圆,兰天鹰,等. 消白方治疗脾肾气虚、湿热瘀阻型慢性肾小球肾炎(CKD1～2期)的临床研究[J]. 上海中医药大学学报,2021,35(6):17-21. DOI:10.16306/j.1008-861x.2021.06.003.
[15] 刘冰,何晓峰. 自拟芪莲护肾煎剂治疗慢性肾小球肾炎55例[J]. 环球中医药,2019,12(8):1258-1261. DOI:10.3969/j.issn.1674-1749.2019.08.035.
[16] 赵晰,王耀光,李蔓,等. 黄文政教授运用脉证合参法治疗慢性肾小球肾炎经验[J]. 天津中医药,2018,35(7):484-486. DOI:10.11656/j.issn.1672-1519.2018.07.02.
[17] 蔡亚宏,蔡文锋,熊丹. 小柴胡汤改善慢性肾小球肾炎患者炎症及减轻蛋白尿的作用研究[J]. 陕西中医,2018,39(10):1405-1407. DOI:10.3969/j.issn.1000-7369.2018.10.028.
[18] 杨小波,利益,郭碧林. 肾炎方联合缬沙坦分散片对慢性肾小球肾炎患者的疗效与肾功能的影响[J]. 世界中医药,2020,15(8):1171-1174. DOI:10.3969/j.issn.1673-7202. 2020.08.016.
[19] 蒲春阳,栗睿. 补气通络、祛湿清热法治疗肾虚热瘀型慢性肾小球肾炎临床疗效及作用机制的研究[J]. 中华中医药学刊,2017,35(6):1556-1559. DOI:10.13193/j.issn.1673- 7717.2017.06.055.
[20] 张之惠. 清利活血养阴方治疗慢性肾小球肾炎临床研究[J]. 中医学报,2017,32(9):1753-1756. DOI:10.16368/j.issn.1674-8999.2017.09.462.
[21] 罗进辉,张慧. 益肾化湿颗粒联合氯沙坦钾片治疗慢性肾小球肾炎的临床观察[J]. 中国药房,2017,28(29):4123-4126. DOI:10.6039/j.issn.1001-0408.2017.29.25.
[22] 张文生,明莉莉,王春梅,等. 肾炎清片对慢性肾小球肾炎血尿治疗效应的队列研究[J]. 中国中西医结合肾病杂志,2017,18(9):816-818. DOI:10.3969/j.issn.1009- 587X.2017.09.022.
[23] 罗寅亮,束永兵,郑昌志,等. 清热降浊、益气活血法治疗慢性肾小球肾炎的临床疗效[J]. 世界中医药,2021,16(17):2622-2625,2630. DOI:10.3969/j.issn.1673-7202. 2021.17.019.
[24] 白正日. 健脾益肾、利湿泄浊法联合雷公藤多苷片对慢性肾小球肾炎患者肾功能、免疫指标及细胞因子的影响[J]. 现代中西医结合杂志,2021,30(2):195-199. DOI:10.3969/j.issn.1008-8849.2021.02.018.
[25] 陈晖,曹昉,袁飞远. 肾复康胶囊结合缬沙坦胶囊对慢性肾小球肾炎疗效、肾功能、血清炎症因子影响研究[J]. 中华中医药学刊,2021,39(9):177-180. DOI:10.13193/j.issn.1673-7717.2021.09.044.
[26] 张瑶琳,葛琪容,罗海波,等. 肾炎舒片联合还原型谷胱甘肽对慢性肾小球肾炎患者血清IL-1、TNF-α、IL-6和尿液mALB的影响[J]. 疑难病杂志,2021,20(3):246-250. DOI:10.3969/j.issn.1671-6450.2021.03.007.
[27] 邱欣,唐银霏,陈新政,等. 脉络宁注射液联合环磷酰胺对慢性肾小球肾炎患者血液流变学、肾功能、PAI-1及t-PA的影响[J]. 长春中医药大学学报,2019,35(2):267-269. DOI:10.13463/j.cnki.cczyy.2019.02.019.
[28] 裴国超,马金荣,赵丽,等. 益肾清利活血方治疗肾虚湿瘀型慢性肾小球肾炎疗效及对患者尿常规、肾功能的影响[J]. 陕西中医,2022,43(4):483-486. DOI:10.3969/j.issn.1000- 7369.2022.04.018.
[29] 孟春萍,王志炜. 补肾祛瘀活血汤辅助治疗慢性肾小球肾炎对患者血清炎性因子及细胞免疫功能的影响[J]. 中国预防医学杂志,2020,21(3):262-266. DOI:10.16506/j.1009- 6639.2020.03.006.
[30] 张晓娟,张燕丽,左冬冬. 川芎的化学成分和药理作用研究进展[J]. 中医药信息,2020,37(6):128-133. DOI:10.19656/j.cnki.1002-2406.200177.